Enrique J. Gómez Aguilera

Prof. Enrique J. Gómez Aguilera

Universidad Poltecnica de Madrid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Diabetes Technology & Therapeutics
Verified
Journal Article
Closed access
CPCarmen Pérez-Gandía
Carmen Pérez-Gandía
AFA. Facchinetti
A. Facchinetti
GSG. Sparacino
G. Sparacino
CCC. Cobelli
C. Cobelli
EAEnrique J. Gómez Aguilera
Enrique J. Gómez Aguilera
MHM.E. Hernando
M.E. Hernando
Background and Aims: Continuous glucose monitoring (CGM) devices could be useful for real-time management of diabetes therapy. In particular, CGM information could be used in real time to predict future glucose levels in order to prevent hypo-/hyperglycemic events. This article proposes a new online method for predicting future glucose concentration levels from CGM data. Methods: The predictor is implemented with an artificial neural network model (NNM). The inputs of the NNM are the values provided by the CGM sensor during the preceding 20 min, while the output is the prediction of glucose concentration at the chosen prediction horizon (PH) time. The method performance is assessed using datasets from two different CGM systems (nine subjects using the Medtronic [Northridge, CA] Guardian® and six subjects using the Abbott [Abbott Park, IL] Navigator®). Three different PHs are used: 15, 30, and 45 min. The NNM accuracy has been estimated by using the root mean square error (RMSE) and prediction delay. Results: The RMSE is around 10, 18, and 27 mg/dL for 15, 30, and 45 min of PH, respectively. The prediction delay is around 4, 9, and 14 min for upward trends and 5, 15, and 26 min for downward trends, respectively. A comparison with a previously published technique, based on an autoregressive model (ARM), has been performed. The comparison shows that the proposed NNM is more accurate than the ARM, with no significant deterioration in the prediction delay. Conclusions: The proposed NNM is a reliable solution for the online prediction of future glucose concentrations from CGM data.

1 November 2011 in Journal of Surgical Research
Verified
Journal Article
Open access
IGIgnacio Oropesa Garcia
Ignacio Oropesa Garcia
PSPatricia Sánchez-González
Patricia Sánchez-González
Pablo LamataPablo Lamata
Pablo Lamata
MCMagdalena K. Chmarra
Magdalena K. Chmarra
J. Blas PagadorJ. Blas Pagador
J. Blas Pagador
EAEnrique J. Gómez Aguilera
Enrique J. Gómez Aguilera
Training and assessment paradigms for laparoscopic surgical skills are evolving from traditional mentor-trainee tutorship towards structured, more objective and safer programs. Accreditation of surgeons requires reaching a consensus on metrics and tasks used to assess surgeons' psychomotor skills. Ongoing development of tracking systems and software solutions has allowed for the expansion of novel training and assessment means in laparoscopy. The current challenge is to adapt and include these systems within training programs, and to exploit their possibilities for evaluation purposes. This paper describes the state of the art in research on measuring and assessing psychomotor laparoscopic skills. It gives an overview on tracking systems as well as on metrics and advanced statistical and machine learning techniques employed for evaluation purposes. The later ones have a potential to be used as an aid in deciding on the surgical competence level, which is an important aspect when accreditation of the surgeons in particular, and patient safety in general, are considered. The prospective of these methods and tools make them complementary means for surgical assessment of motor skills, especially in the early stages of training. Successful examples such as the Fundamentals of Laparoscopic Surgery should help drive a paradigm change to structured curricula based on objective parameters. These may improve the accreditation of new surgeons, as well as optimize their already overloaded training schedules.

5 February 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
Leanne AckermansLeanne Ackermans
Leanne Ackermans
JRJoyce Rabou
Joyce Rabou
MBMaryam Basrai
Maryam Basrai
ASA. Schweinlin
A. Schweinlin
SBStephan C. Bischoff
Stephan C. Bischoff
Taco J. BlokhuisTaco J. Blokhuis
Taco J. Blokhuis
Sarcopenia is a muscle disorder associated with loss of muscle mass, strength and function. Early screening, diagnosis and treatment may improve outcome in different disease conditions. A wide variety of tools for estimation of muscle mass is available and each tool has specific technical requirements. However, different investigational settings and lack of homogeneity of populations influence the definition of gold standards, proving it difficult to systematically adopt these tools. Recently, the European Working Group on Sarcopenia in Older People (EWGSOP) published a revised recommendation (EWGSOP-2) and algorithm for using tools for screening and diagnosing sarcopenia. However, agreement of the EWGSOP2 criteria with other classifications is poor and although an overview of available tools is valuable, for the purpose of clinical decision-making the reverse is useful; a given scenario asks for the most suitable tools. Tools were identified for screening, diagnostics and longitudinal monitoring of muscle mass. For each of these clinical scenarios the most appropriate tools were listed and for each technique their usability is specified based on sensitivity and specificity. Based on this information a specific recommendation is made for each clinical scenario. This narrative review provides an overview of currently available tools and future developments for different clinical scenarios such as screening, diagnosis and longitudinal monitoring of alterations in muscle status. It supports clinical decision-making in choosing the right tools for muscle mass quantification depending on the need within a given clinical scenario as well as the local availability and expertise.

1 August 2002 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
EAEnrique J. Gómez Aguilera
Enrique J. Gómez Aguilera
MHM.E Hernando
M.E Hernando
AGA Garcı́a
A Garcı́a
FPF Del Pozo
F Del Pozo
JCJ Cermeño
J Cermeño
ALA De Leiva
A De Leiva

6 October 2012 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
IGIgnacio Oropesa Garcia
Ignacio Oropesa Garcia
PSPatricia Sánchez-González
Patricia Sánchez-González
MCMagdalena K. Chmarra
Magdalena K. Chmarra
Pablo LamataPablo Lamata
Pablo Lamata
ÁFÁlvaro Fernández
Álvaro Fernández
EAEnrique J. Gómez Aguilera
Enrique J. Gómez Aguilera
The EVA (Endoscopic Video Analysis) tracking system is a new system for extracting motions of laparoscopic instruments based on nonobtrusive video tracking. The feasibility of using EVA in laparoscopic settings has been tested in a box trainer setup. EVA makes use of an algorithm that employs information of the laparoscopic instrument’s shaft edges in the image, the instrument’s insertion point, and the camera’s optical center to track the three-dimensional position of the instrument tip. A validation study of EVA comprised a comparison of the measurements achieved with EVA and the TrEndo tracking system. To this end, 42 participants (16 novices, 22 residents, and 4 experts) were asked to perform a peg transfer task in a box trainer. Ten motion-based metrics were used to assess their performance. Construct validation of the EVA has been obtained for seven motion-based metrics. Concurrent validation revealed that there is a strong correlation between the results obtained by EVA and the TrEndo for metrics, such as path length (ρ = 0.97), average speed (ρ = 0.94), or economy of volume (ρ = 0.85), proving the viability of EVA. EVA has been successfully validated in a box trainer setup, showing the potential of endoscopic video analysis to assess laparoscopic psychomotor skills. The results encourage further implementation of video tracking in training setups and image-guided surgery.

21 January 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ALAgathe León
Agathe León
CCCésar Cáceres
César Cáceres
EFEmma Fernández
Emma Fernández
PCPaloma Chausa
Paloma Chausa
MMMaite Martin
Maite Martin
FGFelipe García
Felipe García
Antiretroviral therapy has changed the natural history of human immunodeficiency virus (HIV) infection in developed countries, where it has become a chronic disease. This clinical scenario requires a new approach to simplify follow-up appointments and facilitate access to healthcare professionals. We developed a new internet-based home care model covering the entire management of chronic HIV-infected patients. This was called Virtual Hospital. We report the results of a prospective randomised study performed over two years, comparing standard care received by HIV-infected patients with Virtual Hospital care. HIV-infected patients with access to a computer and broadband were randomised to be monitored either through Virtual Hospital (Arm I) or through standard care at the day hospital (Arm II). After one year of follow up, patients switched their care to the other arm. Virtual Hospital offered four main services: Virtual Consultations, Telepharmacy, Virtual Library and Virtual Community. A technical and clinical evaluation of Virtual Hospital was carried out. Of the 83 randomised patients, 42 were monitored during the first year through Virtual Hospital (Arm I) and 41 through standard care (Arm II). Baseline characteristics of patients were similar in the two arms. The level of technical satisfaction with the virtual system was high: 85% of patients considered that Virtual Hospital improved their access to clinical data and they felt comfortable with the videoconference system. Neither clinical parameters [level of CD4+ T lymphocytes, proportion of patients with an undetectable level of viral load (p = 0.21) and compliance levels >90% (p = 0.58)] nor the evaluation of quality of life or psychological questionnaires changed significantly between the two types of care. Virtual Hospital is a feasible and safe tool for the multidisciplinary home care of chronic HIV patients. Telemedicine should be considered as an appropriate support service for the management of chronic HIV infection. Clinical-Trials.gov: NCT01117675.